The consumer goods giant has announced that it plans to cut the jobs from its Galderma research and development centre in the south of France.
It comes closely after the company’s Skin Health division announced the upcoming closure of a facility in Switzerland, set to result in as many as 190 job losses.
The downsizing moves come in a bid by the company to make its underperforming skin health business more efficient, according to Reuters.
Nestle, based in Switzerland, is reportedly facing pressure to improve shareholder returns. The company has been experiencing a period of slowing growth over the past few years.
Its Galderma brand started out as a joint venture with L’Oréal, and Nestle took it over completely in 2014. It is now facing cuts of up to 450 of its 550 workforce in its R&D centre near Nice, France.
Speaking on its earlier closure of its swiss facility, Nestle Skin Health confirmed that streamlining its health and skin care operations is a strategic focus.
“Nestle Skin Health is continuously reviewing and adapting its portfolio, simplifying the organization, reviewing its business models, and assessing its geographic footprint,” it said in a statement.
“The move comes as part of Nestlé Skin Health’s global transformation programme, which includes a review of operations worldwide.”
Reuters reports that Nestlé intends to monitor its Galderma facility over the next 12 months, in order to determine which specific activities are worth continuing.
Nestlé Skin Health
Nestlé Skin Health describes itself as one of the category’s leading companies for science-based solutions for skin, hair and nail health.
“Nestlé Skin Health conducts groundbreaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health,” the company says.